Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 37Active not recruiting 30Recruiting 28Terminated 8Withdrawn 5Unknown 5Not yet recruiting 5No longer available 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Neoplasm Metastasis 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × apalutamide × Clear all
NCT07333066 2026-01-12

REINFORCE

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Phase 3 Not yet recruiting
320 enrolled
Genitourinary

Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Medical University of Vienna

Not yet recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

NCT05778097 2023-03-21

ARES

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Not yet recruiting
103 enrolled
Genitourinary

Prostatic Neoplasms

NCT05717582 2023-02-08

CHAMPION

Fudan University

Phase 2 Not yet recruiting
47 enrolled
Genitourinary

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

James J. Peters Veterans Affairs Medical Center

Phase 2 Not yet recruiting
200 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡